NYSE-listed Maia Biotechnology to adopt crypto treasury strategy

NYSE-listed Maia Biotechnology (MAIA) has announced it will pursue a cryptocurrency treasury strategy. The company's board of directors has approved a plan to invest 90% of its liquid assets in cryptocurrencies, with initial purchases planned for Bitcoin, Ethereum, and USDC.